Dr. Mark Luciano is the director of the Johns Hopkins Hydrocephalus and Cerebral Fluid Center. A renowned leader in treating hydrocephalus, Dr. Luciano is distinguished both nationally and internationally for his research and educational and clinical work in neuroendoscopy. Dr. Luciano treats adults with hydrocephalus, pseudotumor cerebri, intracranial hypotension, Chiari malformations, and cerebral and spinal cysts. He has significant expertise treating children and adults with cerebrospinal fluid leaks and congenital disorders. Among his accomplishments in neuroscience research and biomedical engineering are his investigation of the cerebrovascular response to hydrocephalus and the invention of a unique device for control of intracranial pressure (ICP) pulsatility to increase blood flow. His National Institutes of Health-funded studies have explored prolonged compression and hypoxia in the brain as a result of hydrocephalus, as well as the interaction between cerebrospinal fluid and vascular systems. Dr. Luciano is rated as an Elite provider by MediFind in the treatment of Chiari Malformation Type 1. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Increased Intracranial Pressure, Posterior Fossa Decompression, and Gastrostomy.

Dr. Joseph Quillin believes that the practice of neurosurgery is a tremendous privilege. His focus is on durable symptom relief, patient quality of life, maximum safe tumor resection, and the prevention of further neurological damage for his patients. His advanced training in brain, spine, and skull base/cerebrovascular disorders has enabled him to care for some of the most complex patients in neurosurgery. Dr. Quillin specializes in neurosurgical oncology and skull base surgery, using techniques such as radiotherapy and minimally invasive endoscopic surgery to promote tumor treatment and removal. He has served the DFW area since 2021.Dr. Quillin earned his medical degree at Louisiana State University Health Sciences Center in Shreveport. He completed his neurological surgery residency and fellowship training in neurological oncology at Emory University in Atlanta, Georgia. He also completed additional fellowship training in skull base/cerebrovascular surgery at Rutgers University in New Brunswick, N.J. Away from the office, Dr. Quillin has served as an ad hoc reviewer for publications including NEUROSURGERY, World Neurosurgery, and the Journal of Neuro-Oncology. He is a member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Dr. Quillin is rated as an Advanced provider by MediFind in the treatment of Chiari Malformation Type 1. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Herniation, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Hugh Garton is a Neurosurgery provider in Ann Arbor, Michigan. Dr. Garton is rated as an Elite provider by MediFind in the treatment of Chiari Malformation Type 1. His top areas of expertise are Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery.